Skip to content
Screener

Absci Corporation ABSI Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Schrodinger logo
SchrodingerSDGR
$5.71M-0.1%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$12.19M+29.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$62.1M+8.1%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$1.7M-47.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Assembly Biosciences logo
Assembly BiosciencesASMB

Other financials

Income statement

See full
Revenue$318.0K-46.4%
Operating income-$34.2M-8.8%
Net income-$33.2M-8.6%
EPS (diluted)-$0.21+12.5%

Balance sheet

See full
Cash & equivalents$108.9M+97.0%
Total debt$3.7M-32.2%
Total equity$246.1M+42.0%
Total assets$268.9M+28.1%

Cash flow

See full
Operating cash flow-$27.6M-63.4%
CapEx$1.0K-99.6%
Free cash flow-$27.6M-61.2%

Valuation

See full
Market cap$1.51B+271%
Enterprise value$1.41B+293%
P/S969.1×+871×

Profitability

See full
Operating margin-8,084.5%-17,708pp
Net margin-7,756.4%-17,069pp
FCF margin-6,981%-10,936pp

Returns & leverage

See full
Return on equity-57.7%+0.3pp
Debt / equity0.0×
Current ratio10.6×+6.2×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Absci Corporation’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001672688-26-000136
(In thousands, except for share and per share data)June 30, 2026December 31, 2025
Property and equipment, net16,72120,860
Intangibles, net40,05141,514
Restricted cash, long-term1,0541,053
Other long-term assets383383
TOTAL ASSETS$268,917$216,297
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses$16,257$19,348

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's deferred tax assets and other non-current assets?
Absci Corporation (ABSI) reported deferred tax assets and other non-current assets of $383K in Q2 2026.
How has Absci Corporation's deferred tax assets and other non-current assets changed year-over-year?
Absci Corporation's deferred tax assets and other non-current assets decreased by 46.5% year-over-year, from $716K to $383K.
What is the long-term trend for Absci Corporation's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Absci Corporation's deferred tax assets and other non-current assets has grown at a 28.6% compound annual growth rate (CAGR), from $109K to $383K.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Absci Corporation's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude